5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group
Authors
Dearnaley, DSyndikus, I
Mossop, H
Birtle, A
Bloomfield, D
Cruickshank, C
Graham, J
Hassan, S
Khoo, V
Logue, John P
Mayles, H
Money-Kyrle, J
Naismith, O
Panades, M
Patterson, H
Scrase, C
Staffurth, J
Tremlett, J
Griffin, C
Hal, l E
Affiliation
The Institute of Cancer Research/Royal Marsden NHS Trust, Department of Academic Radiotherapy, LondonIssue Date
2015